ACN
Accenture plc
ACN's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over ACN overall, supported by stronger modeled upside and stronger fundamentals.
ACN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ACN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
ACN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $250 | — |
| Current | 18x | $250 | — |
| Cheap | 21x | $285 | +14% |
| Fair | 28x | $381 | +52% |
| Expensive | 33x | $447 | +79% |
Historical ranges are pointers, not guarantees.
ACN's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over ACN in the historical PE scenario, which offers more potential upside but is not a forecast.
ACN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| Moderate |
ACN has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
ACN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.67 | +8.2% |
| Q3 2026 | $13.56 | +12% |
| Q2 2026 | $12.52 | -0.3% |
| Q1 2026 | $12.21 | +0.8% |
| Q4 2025 | $12.10 | +1.5% |
| Q3 2025 | $12.15 | +6.3% |
| Q2 2025 | $12.56 | +15% |
| Q1 2025 | $12.11 | +9.8% |
| Q4 2024 | $11.92 | +10% |
ACN earned $13.56 per share over the past year, up 12% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over ACN on earnings, with more consistent year-over-year improvement.
ACN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +6.2% |
| Q2 2026 | $18.7B | +5.6% |
| Q1 2026 | $18B | +8.3% |
| Q4 2025 | $18.7B | +6% |
| Q3 2025 | $17.6B | +7.3% |
| Q2 2025 | $17.7B | +7.7% |
| Q1 2025 | $16.7B | +5.4% |
| Q4 2024 | $17.7B | +9% |
ACN's revenue has grown year over year for nine quarters in a row: $18.7B last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.7 points |
| Q2 2026 | 17% | +0.1 points |
| Q1 2026 | 14% | +0.3 points |
| Q4 2025 | 15% | -1.3 points |
| Q3 2025 | 12% | -2.7 points |
| Q2 2025 | 17% | +0.8 points |
| Q1 2025 | 13% | +0.5 points |
| Q4 2024 | 17% | +0.9 points |
ACN's operating margin was 15% last quarter, up 3.7 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over ACN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over ACN on profitability, with a higher operating margin.
ACN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8B | -25% |
| Q2 2026 | $3.6B | +2.4% |
| Q1 2026 | $3.7B | +37% |
| Q4 2025 | $1.5B | +73% |
| Q3 2025 | $3.8B | +20% |
| Q2 2025 | $3.5B | +16% |
| Q1 2025 | $2.7B | +35% |
| Q4 2024 | $870.3M | +103% |
ACN's free cash flow has been positive every quarter for seven years: $11.6B over the past year, up 6.9% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over ACN on cash flow, with stronger typical year-over-year growth.
ACN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -10.3M shares |
| 1 year | -3.8% | -24.1M shares |
| 3 years | -5.3% | -34M shares |
| 5 years | -6.2% | -40M shares |
| Available history | -6.8% | -44.1M shares |
ACN has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.3B |
| Q2 2026 | $1.2B |
| Q1 2026 | $1.7B |
| Q4 2025 | $2.3B |
| Q3 2025 | $473.9M |
| Q2 2025 | $1.8B |
| Q1 2025 | $1.4B |
| Q4 2024 | $898.3M |
ACN spent $7.5B buying back its own shares over the past year, up 63% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
ACN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
ACN has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ACN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 88.9 | Overbought |
ACN's weekly RSI is 68 (neutral) and its Stochastic is 89 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
ACN PE vs Technology Sector
| Metric | ACN | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 34% below |
| PE % | 10 | 35 | 25 pts below |
ACN has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
ACN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.0 | 9.2% above |
| 20 week MA | $192.0 | 30% above |
| 50 week MA | $204.9 | 22% above |
| 100 week MA | $250.4 | 0.2% below |
| 200 week MA | $285.4 | 12% below |
ACN has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
ACN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $212.2 | $257.3 | +21% |
| 2021 | $257.3 | $403.3 | +57% |
| 2022 | $403.3 | $266.1 | -34% |
| 2023 | $266.1 | $350.9 | +32% |
| 2024 | $350.9 | $356.2 | +1.5% |
| 2025 | $356.2 | $271.1 | -24% |
| 2026 YTD | $271.1 | $250.0 | -7.8% |
ACN has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.